Results 191 to 200 of about 19,095 (260)

CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. [PDF]

open access: yesNPJ Breast Cancer
House NC   +19 more
europepmc   +1 more source

Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. [PDF]

open access: yesInt J Radiat Oncol Biol Phys
Jacomina LE   +16 more
europepmc   +1 more source

The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study. [PDF]

open access: yesBr J Cancer
Yap TA   +14 more
europepmc   +1 more source

Riesgos geológicos : terremotos

open access: yes, 2008
Alonso Chaves, Francisco Manuel   +2 more
openaire   +3 more sources

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception. [PDF]

open access: yesCancer Discov
Winslow MM   +21 more
europepmc   +1 more source

PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. [PDF]

open access: yesESMO Open
Yap TA   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy